ARCHETYPE Medication substance_modified (openEHR-EHR-CLUSTER.medication_substance_modified.v0)

ARCHETYPE IDopenEHR-EHR-CLUSTER.medication_substance_modified.v0
ConceptMedication substance_modified
DescriptionThe strength and form of the medication substance, including details of specific ingredients where required by an ad-hoc preparation or infusion. *** CHANGED STRENGTH TO CHOICE, ADDED TEXT ELEMENT TO ALLOW VALUE SETS ***
UseFor recording details of a medication preparation with in the context of the original medication order INSTRUCTION and carrying the prescriber's intent, or in the context of a medication ACTION where it serves of a record of the prepartion actually supplied.
MisuseUse in pharmacy stock-control is out-of-scope of the design of this archetype.
PurposeTo record details of a medication preparation, including ,where necessary, details of mutliple ingredients, in the context of an infusion or ad-hoc (extemperaneous) preparation. The majority of dose-based prescriptions will have their precise preparation determined by available ward stock, or by pharmacy supply, while with product-based prescribing, the medication name carries details of the form and strength of the preparation.
ReferencesDerived from: Medication substance, Draft archetype [Internet]. openEHR Foundation, openEHR Clinical Knowledge Manager [cited: 2018-02-08]. Available from: http://www.openehr.org/ckm/#showArchetype_1013.1.2368
openEHR Foundation Medication archetypes http://www.openehr.org/knowledge
NEHTA's Therapeutic Good Use Data Group from the NEHTA Website http://www.nehta.gov.au
Intermountain Healthcare Medication order model, Personal Communication to Sam Heard by Dr Stan Huff.
Royal Australian College of General Practitioners. Fact Sheet: Medicines List. 2010.
Copyright© openEHR Foundation, Alberta Health Services (Canada), openEHR Foundation
AuthorsAuthor name: Sam Heard
Organisation: NEHTA
Email: sam.heard@oceaninformatics.com
Date originally authored: 2015-10-21
Other Details LanguageAuthor name: Sam Heard
Organisation: NEHTA
Email: sam.heard@oceaninformatics.com
Date originally authored: 2015-10-21
Other Details (Language Independent)
  • Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.
  • Custodian Organisation: Ocean Informatics
  • References: Derived from: Medication substance, Draft archetype [Internet]. openEHR Foundation, openEHR Clinical Knowledge Manager [cited: 2018-02-08]. Available from: http://www.openehr.org/ckm/#showArchetype_1013.1.2368 openEHR Foundation Medication archetypes http://www.openehr.org/knowledge NEHTA's Therapeutic Good Use Data Group from the NEHTA Website http://www.nehta.gov.au Intermountain Healthcare Medication order model, Personal Communication to Sam Heard by Dr Stan Huff. Royal Australian College of General Practitioners. Fact Sheet: Medicines List. 2010.
  • Original Namespace: com.oceaninformatics
  • Original Publisher: Ocean Informatics
  • Custodian Namespace: com.oceaninformatics
  • MD5-CAM-1.0.1: B626FEAFBACBF97B35D0E641FBF30C1D
  • Build Uid: 6bda12c9-10f9-4ffe-b98a-92284703e649
  • Revision: 0.0.1-alpha
Keywordsmedication, order, prescribe, therapy, substance, drug, therapeutic, otc, therapeutic good, ad-hoc, extemperaneous
Lifecyclein_development
UID0f6019e7-585a-4c80-b06a-f23106bf246c
Language useden
Citeable Identifier1013.1.1954
Revision Number0.0.1-alpha
Archetype Concept CommentThis is commonly carried as part of the medicine name and provided by the medicines terminology but in some cases must be specified separately.
items
Substance nameSubstance name: The name of the medication substance. This item should be coded if possible.
Usage of substance name will vary according to context of use.
FormForm: The formulation or presentation of the medication.
e.g. 'Tablet', 'Capsule', 'Liquid'.
CategoryCategory: The nature of a compound product, consisting of multiple ingredients.
e.g co-codamol is a combination product, wile 50% white soft paraffin + 50% white soft paraffin is an ad-hoc mixture, whose composition is fully specified within the order.
  • Product [The substance is a manufactured product, containing one or more ingredients.]
  • Ad-hoc mixture [The substance is composed of a mixture of ingredients specificied within this order.]
  • Ingredient [The substance is an individual ingredient of the medication.]
  • Combination product [The preparation consists of a number of ingredients which are pre-combined by the manufacturer.]
  • Single-substance product [The substance is a manufactured product containing a single ingredient.]

Assumed value: Product
StrengthStrength: The value of the strength of the preparation or product as a real number.
e.g. 1, 1.5, 0.125
Choice of:
  •  Quantity
    Property: Qualified real
    Units: >=0.0
  •  Text
Strength unitStrength unit: The dose unit of the medication substance strength.
e.g 'tablet','mg'. Often coded using a reference terminology such as SNOMED CT.
Strength diluentStrength diluent: The amount of any diluent used as part of description of the strenth of the preparation, for both packaged products and ad-hoc mixtures.
e.g. Where a preparation strength is described as '5mg in 10ml', '10ml' is the diluent.
Diluent amountDiluent amount: The value of the amount of diluent as a real number.
e.g 1, 1.5, 0.125 or 1-2, 12.5-20.5
Property: Qualified real
Units: >=0.0
Diluent unitDiluent unit: The unit for the preparation diluent.
e.g. 'ml'.
IngredientIngredient: Details of an ingredient used to make up a mixed preparation or infuson.
This is not normally required other than where an ad-hoc mixture or infusion is being described.
Ingredient substanceIngredient substance: Details of ingredient substance.
Include:
openEHR-EHR-CLUSTER.medication_substance.v0 and specialisations
Ingredient amountIngredient amount: The value of the amount of the ingredient as a real number.
e.g. 1, 1.5, 0.125
Property: Qualified real
Units: >=0.0
Ingredient amount unitIngredient amount unit: The dose unit of the ingredient amount.
e.g 'tablet','mg'. Often coded using a reference terminology such as SNOMED CT.
RoleRole: The role of the ingredient within the mixture or infusion.
Choice of:
  •  Coded Text
    • Therapeutic [The chemical has a known and desired effect which is positive.]
    • Electrolyte [This ingredient is an electrolyte.]
    • Toxic [This chemical is toxic and has no therapeutic effect.]
    • Adjuvant [The chemical is active but aids the therapeutic effect of another ingredient.]
    • Diluent [Inert diluent.]
    • Propellent [Inert propellent.]
    • Preservative [The ingredient is present to prolong the life of the substance.]
    • Colouring [The ingredient is used to colour the substance.]
    • Ingredient [Details of an ingredient used to make up a mixed preparation or infuson.
      This is not normally required other than where an ad-hoc mixture of infusion is being described.]
  •  Text
DescriptionDescription: A text description of the substance where it is not possible to describe this fully using numerical strengths and amounts.
Substance detailsSubstance details: Further details about the medicatin preparation.
e.g. detailed information about the drug class or intended routes.
Include:
All not explicitly excluded archetypes
Other contributorsSilje Ljosland Bakke, Helse Bergen HF, Norway (Editor)
John Bennett, NEHTA, Australia
Sharmila Biswas, Australia
Stephen Chu, NEHTA, Australia (Editor)
Matthew Cordell, NEHTA, Australia
Gail Easterbrook, Flinders Medical Centre, Australia
David Evans, Queensland Health, Australia
Sarah Gaunt, NEHTA, Australia
Trina Gregory, cpc, Australia
Sam Heard, Ocean Informatics, Australia (Editor)
Mary Kelaher, NEHTA, Australia
Robert L'egan, NEHTA, Australia
Heather Leslie, Ocean Informatics, Australia (Editor)
Susan McIndoe, Royal District Nursing Service, Australia
David McKillop, NEHTA, Australia
Chris Mitchell, RACGP, Australia
Stewart Morrison, NEHTA, Australia
Chris Pearce, Melbourne East GP Network, Australia
Camilla Preeston, Royal Australian College of General Practitioners, Australia
Margaret Prichard, NEHTA, Australia
Cathy Richardson, NEHTA, Australia
Robyn Richards, NEHTA - Clinical Terminology, Australia
John Taylor, NEHTA, Australia
Richard Townley-O'Neill, NEHTA, Australia (Editor)
Kylie Young, The Royal Australian College of General Practitioners, Australia
Ian McNicoll, freshEHR Clinical Informatics Ltd., UK
Translators
  • Norwegian Bokmal: John Tore Valand, Gro Hilde Ulriksen, Line Silsand, Helse Bergen Hospital Trust, Norwegian Centre for E-health Research
  • Portuguese: Beatriz de Faria Leao, Bleao Informática em Saúde, bfleao@terra.com.br, MD, PhD